相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Efficacy and safety of ABT-335 (fenofibric acid) in combination with rosuvastatin in patients with mixed dyslipidemia: A phase 3 study
Peter H. Jones et al.
ATHEROSCLEROSIS (2009)
Evaluation of a new formulation of fenofibric acid, ABT-335, co-administered with statins - Study design and rationale of a phase III clinical programme
Peter H. Jones et al.
CLINICAL DRUG INVESTIGATION (2008)
Long-term safety and efficacy of fenofibric acid in combination with statin therapy for the treatment of patients with mixed dyslipidemia
Harold E. Bays et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2008)
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Paul M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Triglycerides and the risk of coronary heart disease - 10 158 incident cases among 262 525 participants in 29 Western prospective studies
Nadeem Sarwar et al.
CIRCULATION (2007)
Additive beneficial effects of fenofibrate combined with atorvastatin in the treatment of combined hyperlipidemia
KK Koh et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Rosuvastatin and fenofibrate alone and in combination in type 2 diabetes patients with combined hyperlipidaemia
PN Durrington et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2004)
ACC/AHA/NHLBI clinical advisory on the use and safety of statins
RC Pasternak et al.
CIRCULATION (2002)
分享论文
